Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Vasomotor Symptoms in Postmenopausal”

15 trials

Showing 15 of 15 results

Testing effectiveness (Phase 2)Study completedNCT00604825
What this trial is testing

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Who this might be right for
Menopausal and Female Climacteric States
GlaxoSmithKline 356
Post-approval studies (Phase 4)Study completedNCT02195609
What this trial is testing

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Who this might be right for
MenopauseHot Flashes
Instituto Palacios 75
Testing effectiveness (Phase 2)Looking for participantsNCT07118891
What this trial is testing

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

Who this might be right for
Vasomotor Symptoms Associated With MenopauseHealthy Volunteers
AbCellera Biologics Inc. 136
Large-scale testing (Phase 3)Study completedNCT00238732
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Who this might be right for
Vaginal Atrophy
Wyeth is now a wholly owned subsidiary of Pfizer 650
Large-scale testing (Phase 3)Study completedNCT00727129
What this trial is testing

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Who this might be right for
Postmenopausal Symptoms
Upsher-Smith Laboratories 495
Testing effectiveness (Phase 2)Ended earlyNCT02653417
What this trial is testing

Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Who this might be right for
Vasomotor SymptomsHot Flashes
Radius Pharmaceuticals, Inc. 139
Large-scale testing (Phase 3)Study completedNCT00535288
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Who this might be right for
Postmenopausal SymptomsMenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 946
Large-scale testing (Phase 3)Study completedNCT04209543
What this trial is testing

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Who this might be right for
Vasomotor SymptomsMenopausal Symptoms
Estetra 1,570
Large-scale testing (Phase 3)Study completedNCT00446199
What this trial is testing

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Who this might be right for
Vasomotor SymptomsHot Flashes
Bayer 735
Testing effectiveness (Phase 2)Looking for participantsNCT07042516
What this trial is testing

Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).

Who this might be right for
Vasomotor Symptoms
Tioga Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT04090957
What this trial is testing

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)

Who this might be right for
Vasomotor SymptomsMenopausal Symptoms
Estetra 1,015
Testing effectiveness (Phase 2)Study completedNCT06726850
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.

Who this might be right for
Vasomotor Syndrome
Changchun GeneScience Pharmaceutical Co., Ltd. 129
Testing effectiveness (Phase 2)Ended earlyNCT01015677
What this trial is testing

MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)

Who this might be right for
Moderate to Severe Vasomotor Symptoms in PostmenopausalWomen
Merck Sharp & Dohme LLC 99
Testing effectiveness (Phase 2)Ended earlyNCT04278872
What this trial is testing

Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Who this might be right for
Hot Flashes
Sojournix, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT03541200
What this trial is testing

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

Who this might be right for
Vasomotor Symptoms (VMS)
Tanabe Pharma America, Inc. 190

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation